Bruker Corporation (BRKR) vs LivaNova PLC (LIVN)
- Bruker Corporation BRKR 54.80 −3.08%
- LivaNova PLC LIVN 77.60 −1.15%
Bruker Corporation and LivaNova PLC are both Medical Devices companies. Bruker Corporation is the larger, with a market value of $8.6B against $4.3B — 2.0× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; LivaNova PLC trades at 22.5×. LivaNova PLC grew revenue faster over the last twelve months: 12.4% against 1.65%. LivaNova PLC has the higher net margin (12.8% vs −3.05%) and the higher return on invested capital (10.6% vs −0.47%). Across the 20 metrics below, LivaNova PLC leads on 16 and Bruker Corporation on 4.
Valuation
Profitability
| Metric | BRKR | LIVN | Medical Devices median |
|---|---|---|---|
| Gross margin | 46.42% | 68.10% | 56.01% |
| Operating margin | (0.87%) | 12.74% | (15.03%) |
| Net margin | (3.05%) | 12.81% | (20.40%) |
| Free cash flow margin | 2.68% | 10.57% | (7.24%) |
| Return on equity | (5.07%) | 15.40% | (15.32%) |
| Return on assets | (1.73%) | 7.33% | (19.72%) |
| Return on invested capital | (0.47%) | 10.63% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack